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Radial symmetry in a chimeric glutamate
receptor pore
Timothy J. Wilding1, Melany N. Lopez1 & James E. Huettner1
Ionotropic glutamate receptors comprise two conformationally different A/C and B/D
subunit pairs. Closed channels exhibit fourfold radial symmetry in the transmembrane
domain (TMD) but transition to twofold dimer-of-dimers symmetry for extracellular ligand
binding and N-terminal domains. Here, to evaluate symmetry in open pores we analysed
interaction between the Q/R editing site near the pore loop apex and the transmembrane M3
helix of kainate receptor subunit GluK2. Chimeric subunits that combined the GluK2 TMD
with extracellular segments from NMDA receptors, which are obligate heteromers, yielded
channels made up of A/C and B/D subunit pairs with distinct substitutions along M3 and/or
Q/R site editing status, in an otherwise identical homotetrameric TMD. Our results indicate
that Q/R site interaction with M3 occurs within individual subunits and is essentially the
same for both A/C and B/D subunit conformations, suggesting that fourfold pore symmetry
persists in the open state.
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I
onotropic glutamate receptors (iGluRs) are ligand-gated ion
channels that mediate excitatory synaptic transmission
throughout the central nervous system. Aberrant activation
of these receptors is implicated in a number of pathological
situations, which has motivated intense effort to understand their
operation and to devise therapeutic interventions that might
allow for the regulation of iGluR activity1. The three main iGluR
subtypes, named for the agonists N-methyl-D-aspartate (NMDA),
a-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid (AMPA)
and kainate (KA), are made up of distinct sets of homologous
subunits that combine as homo or heteromeric tetramers to form
an ion conducting pathway through the membrane1. X-ray
crystallography of subunit subdomains2 and of an intact
homomeric AMPA receptor in the closed state3 has revealed a
modular structure with twofold symmetry in the extracellular
amino terminal and ligand-binding domains (ATD and LBD)
and apparent fourfold symmetry in the channel-forming
transmembrane domain (TMD) (Fig. 1). The iGluR channels
exhibit a pore-helix and selectivity ﬁlter ﬂanked by two
transmembrane helices as originally described for the KcsA
channel4, but with inverted topology. In addition, all eukaryotic
iGluR subunits include an additional transmembrane helix (M4)
that is essential for channel function5–7. In contrast to potassium
channels and most other members of this ion channel
superfamily, the pore loop in iGluRs is on the cytoplasmic face
of the channel and the inner helix bundle crossing, believed to
form the gate to ion passage, faces the extracellular side and
connects to the LBD via short linkers. Motion of the LBD
coincident with agonist binding is thought to pull on the linkers,
inducing a conformational change in the TMD that opens the
channel. Once open, iGluRs conduct monovalent cations and in
some cases calcium ions1.
A striking feature of the intact homomeric GluA2 crystal
structure3 is the presence of two distinct subunit conﬁgurations,
with identical A/C and B/D subunit pairs arranged diagonally
across from each other within the TMD. In the closed state
structure, the transition from twofold to fourfold symmetry
occurs within a narrow zone near the extracellular membrane
surface where the linkers connect the LBD and TMD3. It remains
unclear, however, whether this abrupt symmetry transition
persists when channels open or desensitize. Indeed, several lines
of evidence suggest that in the open state there may be
asymmetries between the A/C and B/D subunit pairs, at least
near the bundle crossing where the extracellular ends of the inner
(M3) helix make close contact to occlude ion passage. For
example, studies of heteromeric NMDA receptors with inner
helix cysteine substitutions in and around the highly conserved
SYTANLAAF motif have demonstrated asymmetric modiﬁcation
for homologous positions of GluN1 versus GluN2 subunits8,
suggesting an offset of the A/C (GluN1) relative to B/D (GluN2)
subunit pairs. In addition, homomeric GluA1 AMPA receptors
with cysteine substitutions in this segment exhibit block by
cadmium ions that is consistent with twofold symmetry in the
open state9. More recent experiments on both AMPA10 and
NMDA11 receptors have provided evidence for differences
between the A/C and B/D subunit pairs in the extent and
timing of gating-associated movements. It remains to be
determined whether these apparent asymmetries are conﬁned to
the extracellular portions of M3, close to the linkers connecting to
the LBD, or whether the entire TMD converts to twofold
symmetry when channels open and/or desensitize12.
To begin addressing this question, we have analysed an
interaction that was recently discovered between residues along
the inner (M3) helix and the Q/R site near the apex of the pore
loop of homomeric GluK2 KA receptors13. The Q/R site is a
location where RNA editing can alter the primary amino-acid
sequence, replacing a polar, but uncharged glutamine (Q)
encoded by genomic DNA with a positively charged arginine
(R). Such editing occurs in the KA receptor GluK1 and GluK2
subunits, as well as the GluA2 subunit of AMPA receptors.
The homologous position remains a Q in all other AMPA and
KA receptor subunits and an asparagine in all GluN1 and
GluN2 NMDA receptor subunits1. Q/R site editing controls a
variety of channel properties1 including ion selectivity and
unitary conductance, as well as susceptibility to inhibition by
polyamines and by cis-unsaturated fatty acids such as arachidonic
and docosahexaenoic acid (AA and DHA).
As shown by recent work13, the GluK2 pore loop Q/R site
interacts with several residues along the inner (M3) helix, most
notably with the side chain at position L614 at the level of the
central cavity (Fig. 1). Moreover, exposure to DHA enhances the
strength of this energetic coupling. For example, in control
conditions Q/R site editing interacts with L614V or D
substitutions with a coupling energy of B2.5 kT, and treatment
with DHA increases the coupling in both cases by an additional
3 kT. The GluK2(R) L614A substitution mutant displays the
largest change with DHA treatment. Whereas wild-type homo-
meric edited GluK2(R) channels are more than 80% inhibited by
exposure to DHA, when editing is combined with the L614A
substitution DHA treatment potentiates agonist-evoked currents
by B10-fold. Although these results in homomeric channels
demonstrated strong interaction between the Q/R site and M3
helix, they did not reveal whether the interaction is equivalent for
all four subunits or whether there are substantial differences
between the relative contributions of the A/C and B/D subunit
pairs. In addition, work to date has not determined whether the
Q/R site to M3 interaction occurs within an individual subunit or
across the boundary between two adjacent subunits13,14.
In this study, to address these questions we have constructed
chimeric channels that combine the TMD and cytoplasmic
carboxy terminal domain (CTD) of the GluK2 kainate receptor
subunit with the extracellular ATD and LBD of NMDA receptor
subunits GluN1 and GluN2B. Because NMDA receptors are
obligate heteromers1 and the extracellular domains are strongly
implicated in specifying the heteromeric arrangement of subunits
within tetrameric channels15, we reasoned that functional
channels would only be generated when both GluN1/GluK2
and GluN2B/GluK2 chimera were co-expressed, which turned
out to be the case. In this way we were able to construct channels
with A/C and B/D subunits that differed in their Q/R editing or
M3 substitutions, or both. Using this approach, we show that
interactions between the Q/R site and M3 helix occur within each
subunit, not between adjacent subunits, and that pore loop to M3
interactions within the A/C and B/D subunit pairs make nearly
equal contributions to the potentiation elicited by treatment with
DHA, suggesting that the fourfold radial symmetry observed for
the closed state TMD is preserved when channels open, at least
up to the level of the central cavity.
Results
Chimeric subunits with a kainate receptor pore. Previous efforts
to transplant just the M1 to M3 segment between NMDA and KA
receptor subunits met with limited success16, probably because
interaction of the M1 to M3 pore with the M4 transmembrane
helix is now recognized to be essential for channel assembly7 and/
or function5,6. Therefore, we combined the entire KA receptor
TMD including the linkers to the LBD, as well as the CTD, with
the extracellular domains from NMDA receptor subunits GluN1
and GluN2B (Fig. 1).
In wild-type NMDA receptors glutamate or NMDA binds to
the GluN2 subunit, whereas the co-agonist glycine or D-serine
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binds to GluN1 (ref. 1). In addition, recent work17,18 supports the
assignment3 of GluN1 to the A/C conﬁguration and GluN2 to
the B/D conﬁguration (but see ref. 19). As shown in Fig. 2a
expression of each chimeric subunit alone, in either the
unedited (Q) or edited (R) form, failed to generate functional
homomeric channels; however, co-expression of the GluN1-
GluK2 pore (N1/K2) and GluN2B-GluK2 pore (N2B/K2)
chimeric subunits together resulted in channels that were
activated by application of NMDA and the co-agonist
glycine20,21. As for wild-type full-length GluK2, when both
subunits were unedited (Q) in the pore loop, the resulting
channels displayed bi-rectifying current-voltage relations
(Fig. 2b) indicative of voltage-dependent block by cytoplasmic
polyamines1. In contrast, if one or both subunits was in the edited
(R) form, then polyamine block was diminished and the IV
relation was linear (Fig. 2c–e), or showed slight outward
rectiﬁcation22. Importantly, exposure to DHA strongly inhibited
channels in which all of the subunits were edited (R) in the pore
loop but caused little or no change in channels with either or
both subunits in the unedited (Q) form (Po0.0001, one-way
ANOVA with post hoc Student-Newman-Keuls comparison)
(Fig. 3), which is identical to the pattern of DHA modulation
observed for wild-type full-length recombinant heteromeric
kainate receptors23 (Fig. 3c). A similar outcome was obtained
with constructs in which the CTD, as well as the ATD and LBD,
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Figure 1 | Glutamate receptor domain structure. (a) Chimeric glutamate receptor homology model based on the homomeric GluA2 AMPA receptor
closed state X-ray structure (Sobolevsky et al.3) illustrating the amino-terminal domain (ATD), ligand-binding domain (LBD) and transmembrane domain
(TMD). The cytoplasmic carboxy terminal domain (CTD) was not resolved or modelled. Each subunit is shown in a different colour. In wild-type
NMDA receptors GluN1 and GluN2B subunits are in the A/C and B/D conformations, respectively. (b) Diagram of the four domains in two chimeric
subunits of a heteromeric receptor highlighting the pore loop and M1-M4 alpha helices in the TMD derived from KA receptor subunit GluK2 (white roman
numerals I, II, III, IV). Left hand subunit is unedited (Q) at the apex of the pore loop and wild type L614 in M3 at the level of the central cavity. Right hand
subunit is edited (R) and mutated (L614A) in M3. Subunits with N1 and N2B extracellular domains are presumed to be adjacent in functional tetramers
(below), but for clarity are positioned opposite each other in the diagram. (c) Enlarged side and axial views of the homology model showing the lower
portion of the LBD in faint teal (GluN1) and red (GluN2B), as well as the TMD and linkers from GluK2 in full colour. The view down the central axis from the
extracellular domains illustrates differences in the A/C and B/D linkers. (d) Sequence alignment for chimeric GluN1 and GluN2B with GluK2. Green
triangles indicate the position of joints in the chimeric subunits. The purple triangle indicates an additional joint for subunits that only included the TMD
from GluK2. Numbering is for the mature wild-type proteins. Secondary structure is shown as cylinders (a-helices), arrows (b-strands) and lines (loops) in
grey above the sequence. * indicates the Q/R/N site in the pore loop and the GluK2 L614A mutation site in M3.B indicates the M3 Ala at the middle of
the bundle crossing. The W in M2 of GluN1 and the S in M3 of GluN2B that interact with each other (Siegler Retchless et al.14) are underlined.
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Taken together, these results demonstrate that the kainate
receptor TMD is sufﬁcient to determine the effect of DHA
exposure: inhibition when all four subunits are edited (R), but
neither inhibition nor potentiation when one or both subunits is
unedited (Q). Thus, the NMDA receptor ATD and LBD domains
effectively activate all of the edited and unedited GluK2 pore
combinations but are not able to prevent inhibition of R/R pores
by DHA or to induce potentiation of Q/R, R/Q or Q/Q pores24,25.
Collectively, these results strongly suggest that AA and DHA act
by partitioning into the membrane and directly or indirectly
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Figure 2 | Whole-cell current and current-voltage relations for channels
with kainate receptor pores. (a) Whole-cell current (mean±s.e.m.)
evoked by 10mM NMDA plus 10 mM glycine in HEK 293 cells transfected
with edited (R) or unedited (Q) N1/K2 and N2B/K2 chimeric subunits.
Agonist application did not elicit current in cells transfected with the N1/
K2(Q/R) or N2B/K2(Q/R) subunits alone. Sample size is shown for each
bar. (inset) Current recorded from a cell transfected with N1/K2(Q)þN2B/
K2(Q). (b–e) Whole-cell currents evoked by 10 mM NMDA and 10mM
glycine as the membrane potential was ramped from  160 to þ 110mV at
0.75mvms 1. (b) Birectiﬁcation of current mediated by N1/K2(Q)þN2B/
K2(Q) reﬂects block by endogenous polyamines, as well as 20mM
spermine added to the internal solution, with relief of block as the
polyamines permeate the channel at positive potentials. Polyamine block
was eliminated by Arg substitution at the Q/R site of either the N1/K2 (c)





































Figure 3 | Selective DHA inhibition of fully edited chimeric receptors.
Whole-cell current evoked by 10 mM NMDA and 10mM glycine (open bars)
at 80mV before and after exposure to 30 mM DHA (solid bar) in a cell
transfected with fully edited N1/K2(R)þN2B/K2(R) subunits (a) and in a
cell that received N1/K2(Q)þN2B/K2(R) (b). (c) Plot of current evoked
immediately after exposure to DHA as a fraction of control current before
DHA (mean±s.e.m.) for the four chimeric combinations and, for
comparison, wild-type homomeric GluK2(Q) and (R) and heteromeric
GluK2(R)þGluK5(Q). Sample size is shown for each bar. * signiﬁcantly
different from N1/K2(Q)þN2B/K2(Q) and homomeric GluK2(Q)
(Po0.0001, one-way ANOVA with post hoc Student-Newman-Keuls
comparison).
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Q/R site interaction with the M3 helix. Recent work on
homomeric GluK2 KA receptors has demonstrated that several
amino acids along the inner transmembrane helix (M3) interact
selectively with the Arg side chain at the Q/R site in fully edited
channels13. In particular, a number of substitutions at position
L614 completely reverse the effect of DHA exposure on GluK2(R),
while having little or no effect on GluK2(Q). Substitution of L614
with alanine had the largest effect, convertingB90% inhibition of
wild-type GluK2(R) to approximately 10-fold potentiation for
homomeric GluK2(R)L614A (ref. 13). To determine the relative
contribution of the A/C and B/D subunit pairs to this interaction
and to test whether it occurs between adjacent subunits or within
individual subunits, we made Q and R forms of both GluN1/K2
and GluN2B/K2 each bearing alanine substituted for the leucine
homologous to L614 in full-length GluK2 (henceforth referred to
as L614A substitutions in the chimeric subunits). As shown in
Fig. 4, all 12 of the possible heteromeric combinations of mutant
and non-mutant subunits were functional and a clear pattern
emerged for modulation of channel function by DHA: ﬁrst, the
strongest potentiation by DHA (410-fold) occurred when all four
subunits were both edited (R) and mutated (L614A); second,
intermediate potentiation (two- to fourfold) was observed when
one of the two chimeric subunits was both edited (R) and mutated
(L614A); third, less than 1.5-fold potentiation occurred when the
L614A mutation was only present in unedited (Q) subunits
(Po0.0001, one-way ANOVA with post hoc Student-Newman-
Keuls comparison).
Together, the results in Fig. 4 provide strong evidence that the
Arg side chain in edited Q/R sites interacts with the residue at
position 614 within the same subunit. Channels that included an
edited (R) subunit wild type at L614 and an L614A mutation on
the adjacent unedited (Q) subunit displayed no signiﬁcant
potentiation relative to completely unedited (Q/Q) combinations.
However, combinations in which both subunits were edited (R)
but only one of them bore the L614A mutation exhibited stronger
potentiation than combinations with one or both subunits
mutated (L614A) but only one subunit edited (R) (Po0.0001,
one-way ANOVA with post hoc Student-Newman-Keuls
comparison) (Fig. 4e), suggesting that conﬁnement of four Arg
guanidinium groups within the pore enhances the interaction
with M3. Thus, the effect of DHA is strongest when all four
subunits are edited at the Q/R site, whether the effect is
inhibition, as for wild-type L614, or potentiation, with either
two or four L614A substitutions.
Importantly, the Q/R site interaction with M3 is likely to be
equivalent in both the A/C and B/D subunit pairs because a
similar level of potentiation was observed for channels that
included either the N1/K2(R)L614A or the N2B/K2(R)L614A
constructs (Fig. 5). The only evidence for asymmetry came from
the N1/K2(R)L614AþN2B/K2(Q) combination that displayed
weaker potentiation by DHA than any of the other constructs
with L614A on an edited (R) subunit (P¼ 0.002, one-way
ANOVA with post hoc Student-Newman-Keuls comparison)
(Fig. 4e). Despite this difference, there was strong correlation
between the effects of DHA on symmetric construct pairs
(Fig. 5b) (Pearson correlation coefﬁcient¼ 0.925 for the 6
off-diagonal points; P¼ 0.0083 that the association is invalid;
regression line for the off-diagonal points in cyan and extended to
the axes in red). Indeed, the relation between analogous pairs of
N1/K2 and N2B/K2 constructs was well described by a model
assuming fourfold radial symmetry (F test) (Fig. 5b, perfect
symmetry indicated by the dashed line).
Decoupling the co-agonist sites. In addition to increasing
agonist-evoked currents, in some cases exposure to DHA
also increased the baseline holding current (for example,
Figs 4d and 6a). The magnitude of the change varied from
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Figure 4 | Intrasubunit interaction between the pore loop and M3 helix.
Whole-cell current evoked by 10 mM NMDA and 10mM glycine (open bars)
at  80mV before and after exposure to 30mM DHA (solid bar) in cells
co-transfected with N1/K2(R)þN2B/K2(Q)L614A (a), N1/K2(R)L614Aþ
N2B/K2(Q)L614A (b), N1/K2(Q)þN2B/K2(R)L614A (c), or N1/K2(R)
L614AþN2B/K2(R)L614A (d). (e) Plot of current evoked immediately
after exposure to DHA as a fraction of control current before DHA
(mean±s.e.m.) for the 12 chimeric constructs and, for comparison,
homomeric L614A mutants of GluK2(Q) and (R). Sample size is shown for
each bar. Note the logarithmic scale. DHA had minimal effect when L614A
and Q to R editing were not present on the same chimeric subunit;
green horizontal bar indicates the 95% conﬁdence interval (CI) for
N1/K2(Q)L614A þN2B/K2(Q)L614A. Signiﬁcant potentiation was
observed when one of the two subunits included the L614A substitution
and Q to R editing (Po0.0001, one-way ANOVA with post hoc Student-
Newman-Keuls comparison); 95% CI for N1/K2(Q)L614A þN2B/
K2(R)L614A (yellow bar). Potentiation was greatest when both chimeric
subunits were edited (R) and mutated (L614A); 95% C.I. for
N1/K2(R)L614AþN2B/K2(R)L614A (pink bar).
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combinations that also showed the greatest potentiation of ago-
nist-evoked current (Fig. 6b), raising the possibility that DHA was
either increasing the open probability of unliganded chimeric
channels26,27 or enhancing channel activation by trace levels
of agonist that might be present in our control external
solution20,21,28. If the change in baseline involved activation by
trace agonist levels, then it should be blocked or reversed by co-
application of competitive antagonists, which was indeed the case
for antagonists of the GluN1 glycine-binding site including ACEA
1021 (ref. 29) and 5-ﬂuoro-indole-2-carboxylic acid (5F-I2CA)30,
whereas competitive inhibitors of the GluN2 glutamate/NMDA-
binding site, such as APV and CPP31, had less effect (Fig. 6c,d).
Analysis of macroscopic21,32,33 and single channel34–36
currents suggest that efﬁcient opening of wild-type NMDA
receptor channels requires agonist occupancy of all four LBDs,
with both GluN1 subunits binding glycine or D-serine and both
GluN2 subunits binding glutamate or NMDA. In contrast,
AMPA and kainate receptors can open with only a subset of
the four agonist-binding sites occupied37–39. Our initial results
with chimeric subunits showed that production of functional
channels requires co-expression of N1/K2 and N2/K2 subunits
(Fig. 2a) but did not determine whether simultaneous occupancy
of both the glycine and NMDA sites is essential for channel
activation. To test for channel activation by NMDA alone we
recorded dose-response relations for NMDA in the presence of a
glycine site antagonist (1mM 5F-I2CA) and no added glycine and
normalized to current evoked in the same cells by 1mM NMDA
plus 10mM glycine and no antagonist (Fig. 7a–d). Currents were
recorded both before and after exposure to DHA to see whether
there was any change in apparent afﬁnity or efﬁcacy. For cells
transfected with N1/K2(Q)þN2B/K2(Q), there was little
evidence for channel activation by NMDA alone (Fig 7a,c;
n¼ 4 cells), either before or after DHA treatment. In contrast,
NMDA alone evoked almost 30% as much current as NMDA plus
glycine in cells co-transfected with the M3 mutant subunits
N1/K2(R)L614Aþ N2B/K2(R)L614A (Fig. 7b,d; n¼ 6 cells).
Moreover, treatment with DHA produced an equivalent increase
in currents evoked by NMDA alone or with glycine, such that
there was no signiﬁcant change in the normalized dose-response
relation (Fig. 7d; F test).
To test for channel activation by glycine alone, we recorded
glycine dose-response relations in external solutions without
added NMDA or glutamate (Fig. 7e–h), and in some cases
including NMDA site competitive antagonists (either 50 mM APV
or 30 mM CPP). Currents recorded before or after exposure to
DHA were normalized to the control response evoked by 100mM
NMDA plus 10 mM glycine. In contrast to NMDA, application of
glycine alone evoked substantial currents in cells expressing
either the non-mutant N1/K2(Q)þN2B/K2(Q) (0.5 of control,
n¼ 6 cells) or the mutant N1/K2(R)L614AþN2B/K2(R)L614A
chimeric subunits (0.4 of control, n¼ 10 cells) (Fig. 7e–h).
Importantly, there was little difference in the half-maximal dose
(EC50) for glycine between the two construct combinations (0.6
and 0.8 mM, respectively; t-test, P¼ 0.52) and no signiﬁcant
change in the EC50 following treatment with DHA (F test).
Collectively, these results suggest a loss of the strict requirement
for all four agonist sites to be occupied in order for channels to
open. Instead, chimeric channels that include the GluK2 TMD
and linkers appear to be activated by glycine alone, or by NMDA
alone for the M3 mutant constructs, with only a modest reduction
in efﬁcacy compared with co-application of both agonists
together. The EC50 values for activation of chimeric constructs
by glycine or NMDA alone are somewhat lower than observed for
intact wild-type subunits29 or neuronal NMDA receptors30,40,
which might reﬂect a difference in linkage from LBD to TMD41































































Figure 5 | Radial symmetry in chimeric receptor pores. (a) Interaction
matrix for Q/R editing and L614A substitutions to chimeric N1/K2 and
N2B/K2 subunits. Matrix elements display IDHA/Icontrol as mean±s.e.m.
(no. of cells). Colour code: No Aþo2R, white; No Aþ 2R, grey; A not with
R, green; 1R with 1 or 2 A, yellow; 1A with 2R, tan; 2A with 2R, pink.
(b) Diamonds plot IDHA/Icontrol for the four main diagonal elements
(Mji versus Mij where i¼ j) outlined in bold in (a). Circles plot IDHA/Icontrol
in N2B/K2 versus N1/K2 for symmetric constructs (off-diagonal matrix
elements, Mji versus Mij and iaj). Pearson product moment correlation
coefﬁcient¼0.925 for the six off-diagonal points indicates strong
symmetric association (P¼0.0083 that the association is invalid). In
addition, linear regression to the six off-diagonal matrix element points
(solid line, 2 parameters) was not statistically superior (F test) to the line of
identity through the symmetric main diagonal elements (dashed line, no
free parameters). The solid line is shown in cyan over the range of off-
diagonal points used for regression. It is extended to each axis in red. * only
the N1/K2(Q) þN2B/K2(R)L614A, N1/K2(R)L614AþN2B/K2(Q)
coordinate pair displayed signiﬁcant asymmetry (P¼0.002, one-way
ANOVA with post hoc Student-Newman-Keuls comparison).
ARTICLE NATURE COMMUNICATIONS | DOI: 10.1038/ncomms4349
6 NATURE COMMUNICATIONS | 5:3349 | DOI: 10.1038/ncomms4349 | www.nature.com/naturecommunications
& 2014 Macmillan Publishers Limited. All rights reserved.
lack of negative allosteric coupling between agonist-binding
sites33,40 when only one agonist is applied.
Discussion
Our results support several conclusions about the structure and
operation of iGluRs and their modulation by cis-unsaturated
fatty acids. Despite minimal sequence identity1, the heteromeric
extracellular ATD and LBD from NMDA receptor subunits
GluN1 and GluN2B were able to operate the homomeric
TMD from the GluK2 kainate receptor subunit, conﬁrming the
modular arrangement of iGluRs42–44. Moreover, the GluK2 TMD
embedded within the chimeric subunits can completely reproduce
the modulatory effects of DHA observed for full-length homo-
meric wild-type GluK2 (ref. 23) and for the M3 helix L614A point
mutation in homomeric GluK2 channels13. These results strongly
suggest that modulation of GluK2 by DHA involves a direct effect
on the TMD via the membrane. In addition, our results provide
strong evidence that an edited pore loop Q/R site Arg side chain
interacts with the M3 helix13 within an individual subunit rather
than between adjacent subunits. Substantial potentiation by
exposure to DHA was only observed when both Q to R editing
and L614A substitution were present on the same chimeric
subunit. Because a similar level of potentiation was observed for
L614A substitution of either the N1/K2(R) or N2B/K2(R)
subunits, our results also suggest that the pore retains fourfold
radial symmetry in the open state, at least up to the level of the
central cavity. Finally, our results demonstrate decoupling of
the co-agonist sites in chimeric receptors, suggesting that linkage
between the LBD and TMD underlies the strict requirement
of intact wild-type NMDA receptors for occupation of both
the agonist and co-agonist sites to promote channel opening
(see also ref. 27).
Previous work on chimeric iGluRs has involved transferring
domains within the members of a subfamily (that is, GluN2A and
GluN2B45,46 or GluK1 and GluK2 (ref. 47)) or between AMPA
and kainate receptors43,44, which are more closely related to each
other (B30–40% identity) than to any of the NMDA receptor
subunits (o20% identity)1. Chimeric subunits with the M1-M3
segment from GluN1 transferred into GluK2 form functional
homomeric channels16; however, similar constructs using the
M1-M3 portion of GluN2B are not functional as homomers and
do not combine with the GluK2(GluN1 M1-M3) chimera16.
Moreover, homomeric GluK2/GluN1 (M1-M3) channels do not
exhibit voltage-dependent block by Mg16, which is a hallmark of
native NMDA receptors1. On the basis of increasing evidence that
the M4 transmembrane helix is essential for channel function5–7,
we fused the entire TMD and extracellular linkers plus the
cytoplasmic C-terminal tail of GluK2 to the extracellular
ATD and LBD from GluN1 and GluN2B, including from the
NMDA receptor subunits both the S1 segment preceding M1 and
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Figure 6 | Changes in holding current with DHA and antagonists. (a) Whole-cell current evoked by 10mM NMDA and 10mM glycine (open bars)
before and after exposure to 15mM DHA (black bars). The glycine site antagonist ACEA 1021 (1mM) was applied together with DHA during the periods
indicated by the grey bars. After the ﬁnal exposure to DHA, the control external solution contained 0.1% BSA. (b) Plot of current evoked immediately
after exposure to DHA (mean±s.e.m.) as a fraction of control current before DHA for the 12 chimeric constructs in Fig. 4 versus change in holding current
with DHA exposure normalized to the current evoked by NMDA and glycine. Pearson product moment correlation coefﬁcient¼0.949 (Po0.0001).
Sample size as given in Figs 4e and 5a. (c) Percent block of DHA-induced change in holding current (mean±s.e.m.) for N1/K2(R)L614AþN2B/
K2(R)L614A by 1mM ACEA 1021 or 1mM 5F-I2CA (20 cells) or by 50mM APV or 30mM CPP. Sample size is shown for each bar. (d) Percent change in
baseline holding current (mean±s.e.m.) without DHA exposure.
NATURE COMMUNICATIONS | DOI: 10.1038/ncomms4349 ARTICLE
NATURE COMMUNICATIONS | 5:3349 | DOI: 10.1038/ncomms4349 | www.nature.com/naturecommunications 7
& 2014 Macmillan Publishers Limited. All rights reserved.
Co-transfection of N1/K2þN2B/K2 subunits resulted in
functional channels activated by NMDA and/or glycine.
However, transfection of individual chimeric subunits alone
failed to generate functional homomeric channels, consistent with
the fact that NMDA receptors are obligate heteromers1 and that
the extracellular domains appear to play a major role in
heteromer assembly15. Further experiments will be needed to
determine whether chimeric subunits expressed alone fail to make
it to the cell surface, or whether they assemble and transit to the
surface as non-functional oligomers.
Native iGluRs exhibit divergent modulation by AA and DHA.
NMDA receptor-mediated currents potentiate two- to threefold
by an increase in channel open probability24,25. Neuronal KA
receptors48 and fully edited recombinant channels23 are strongly
inhibited by AA and DHA, owing to a reduction in open
probability49. Whereas AMPA receptors and recombinant KA
receptors that include unedited (Q) wild-type subunits are
relatively unaffected23,50. It remains unclear whether iGluR
modulation by AA and DHA involves speciﬁc interaction with
hydrophobic segments in the extracellular, intracellular or
transmembrane portions of each subunit or whether it reﬂects
sensitivity to changes in bulk properties of the membrane,
analogous to the effect of membrane stretch on NMDA receptor
gating51. Using chimeric constructs, wild type at M3 position
L614, we found that the GluK2 TMD completely recapitulates the
pattern of DHA modulation observed for full-length homo and
heteromeric kainate receptors: strong inhibition of fully edited
(R)/(R) channels, but little effect on channels that included
unedited subunits. Signiﬁcantly, there was no potentiation of
unedited (Q)/(Q) chimeric channels, as might have been expected
if DHA were to interact with hydrophobic regions of the NMDA
receptor ATD, which are known to regulate activity of full-length
NMDA receptors15,52. Although our results do not formally rule
out such interactions with the ATD, they show that KA receptor
modulation is completely determined by the TMD, suggesting
that channel regulation likely depends on contacts within the
membrane.
Recent experiments on NMDA receptors14 showed that unitary
conductance, calcium permeability and the strength of
magnesium block depend on an intersubunit interaction
between a conserved M2 helix Trp residue in GluN1 and an
M3 helix Ser (GluN2A and 2B) or Leu (GluN2C or 2D) in the
adjacent GluN2 subunit (see Fig. 1d). Work on homomeric
kainate receptor channels formed by GluK2 has also provided
evidence for interactions between the pore loop and residues
along the M3 helix13; however, our results in the present study
indicate that interactions between Q/R site Arg residues and
L614A at the level of the central cavity occur within an individual
subunit rather than between adjacent subunits. In channels with
one pair of edited (R) and one pair of unedited (Q) chimeric
subunits, DHA caused strong potentiation only when the edited
(R) subunits included the L614A mutation. Alanine substitution
at L614 of unedited (Q) subunits had little or no effect regardless
the mutation status at L614 of the adjacent edited (R) subunits. In
contrast, channels with one pair of mutated (A) and one pair of
wild type (L) subunits at position 614 exhibited stronger
potentiation if both subunits were edited (R) than if the wild-
type L614 subunits were unedited (Q), which may reﬂect
interaction between adjacent Q/R site arginines in fully edited
channels. By far the strongest potentiation occurred when an
edited Q/R site and the L614A mutation were present on both
chimeric subunit pairs, or on all four of the subunits in a
homomeric full-length GluK2(R)L614A channel13.
Agonist binding to iGluRs induces clam shell closure of the
LBD53 that is thought to open channels by exerting force on the
extracellular ends of the transmembrane helices via short random
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Figure 7 | Decoupling of co-agonist sites. (a,b) Whole-cell currents
evoked by 1mM NMDA and 10mM glycine (solid bars), then by 1mM, 10, 1
and 0.1mM NMDA alone (open bars) in the presence of 1mM 5F-I2CA, a
glycine site antagonist (grey bars). N1/K2(Q)þN2B/K2(Q) (a) and
N1/K2(R)L614AþN2B/K2(R)L614A (b) before (top) and after (bottom)
exposure to 15mM DHA. (c,d) Currents (mean±s.e.m.) evoked by NMDA
alone plus 1mM 5F-I2CA (circles) normalized to 1mM NMDA plus 10mM
glycine (diamonds), before (open) and after (ﬁlled) exposure to DHA.
Smooth curve: best Hill equation ﬁt to NMDA alone (with 5F-I2CA) before
and after DHA, EC50¼ 1.7mM, n¼ 2.1 and Imax¼0.28 (6 cells).
(e,f) Current evoked by 100mMNMDA plus 10mM glycine (solid bars), then
by 50, 10, 2, 0.4, 0.08 and 0.016mM glycine alone (open bars). Traces from
N1/K2(Q)þN2B/K2(Q) before DHA (e) and from N1/K2(R)L614Aþ
N2B/K2(R)L614A after DHA (f). (g,h) Currents (mean±s.e.m.) evoked by
glycine alone (circles) normalized to 10mM NMDA plus 10mM glycine
(diamonds), before (open) and after (ﬁlled) exposure to DHA. Smooth curves:
best Hill equation ﬁt to glycine alone before and after DHA for N1/
K2(Q)þN2B/K2(Q) (g) with EC50¼0.79 mM, n¼0.82 and Imax¼
0.51 (6 cells) and for N1/K2(R)L614AþN2B/K2(R)L614A (h) with
EC50¼0.57mM, n¼0.87 and Imax¼0.38 (10 cells). Exposure to DHA did
not signiﬁcantly alter the concentration response relations for NMDA
alone (c,d) or glycine alone (g,h) (F test).
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coil linkers3. In the process of opening, portions of the TMD
might convert from fourfold symmetry in the closed state to
twofold symmetry in the open state10. A number of studies8,27,41
provide evidence for asymmetries in and around the pore of
NMDA receptors, but whether these reﬂect local effects of the
substantial differences in primary sequence between GluN1 and
GluN2 subunits (Fig. 1d) or more global dissimilarities in subunit
conformation within the TMD remains uncertain54. Importantly,
analysis of cadmium binding to homomeric GluA1 AMPA
receptors with an Ala to Cys substitution in the conserved M3
SYTANLAAF motif (indicated by an open diamond in Fig. 1d)
provides evidence for twofold symmetry at the level of the
bundle crossing9, which is thought to form the gate for ion ﬂow.
In the closed state crystal structure3, however, this conserved
alanine lies right at the transition from twofold to fourfold
symmetry. Thus, it remains to be determined whether the sharp
closed state transition in symmetry is preserved in the open state
or whether local twofold symmetry extends further down the
transmembrane helices when channels open and/or desensitize12.
The present study evaluates an interaction approximately three
turns down the M3 helix in a zone of strong fourfold symmetry in
the closed state3; moreover, our results suggest that fourfold
symmetry persists at this position when channels are open.
This interpretation is most compatible with an alternating
N1-N2-N1-N2 arrangement for chimeric subunits imposed by
the extracellular NMDA receptor segments15. Although sub-
stantial evidence supports this organization3,17,18, there is also
some data that instead favours an adjacent N1-N1-N2-N2
arrangement5,19, and our results cannot entirely exclude an
adjacent organization. It is also notable that DHA regulates
channels whether applied in the presence or absence of agonist,
with kinetics of onset and recovery from modulation that are
much slower than gating transitions13,23. Thus, it seems unlikely
that our evidence for radial symmetry reﬂects a selective inter-
action that is exclusive to the fourfold symmetric closed state.
Despite the fact that formation of functional channels requires
co-expression of both chimeric N1/K2 and N2B/K2 subunits, our
results show that currents can be activated by glycine alone, or in
some cases NMDA alone, suggesting that the LBD does not
dictate the strict requirement of intact NMDA receptors for dual
occupancy by both agonists. Instead, it suggests that the need for
all four agonist sites to be occupied depends on linkage between
the LBD and TMD that is unique for NMDA receptors. Previous
work on NMDA receptors with point mutations in GluN1 at the
bundle crossing (replacement of alanine homologous to that in
GluA1 mentioned above, see Fig. 1d) also provided evidence for
co-agonist site decoupling27, but mutations in this region are
known to interfere with normal gating26. In contrast, L614, which
was mutated to alanine in the present study, is well below the
bundle crossing, and co-agonist site decoupling was also observed
for the N1/K2(Q) þN2B/K2(Q) combination with no M3
mutations. Importantly, both KA and AMPA receptor channels
can open with less than complete agonist occupancy37–39, and
our results suggest that this property can be transferred by
transplantation of the GluK2 TMD together with the short linkers
that extend up to the LBD. Analysis of additional chimeric
constructs with fusion joints closer to the TMD may reveal more
about the structural basis for differential occupancy requirements
between the iGluR family members.
Methods
cDNA constructs and cell culture. Subunit cDNAs, generously provided by Steve
Heinemann, Peter Seeburg, Mark Mayer and Stefano Vicini, were all expressed
from the pRK5 vector using the GluK2 signal sequence. Chimeric subunits
were generated by a restriction enzyme (RE)-free PCR cloning method55 or by
ligation of PCR products with novel restriction sites inserted by silent mutations.
The RE-free method involves two sense and two antisense primers for each joint
that creates a 15 bp complementary overlap55 (underlined). S1 to M1 joint: sense
GluK2 CCCAATGGTACAAACCCAGG and CCAGGCGTCTTCTCCTTCCTG,
antisense GluN1 GTTTGTACCATTGGGCTTCTTGACCAAAATGGTCAGGC
and CTTCTTGACCAAAATGGTCAGGC; antisense GluN2B GTTTGTACCATT
GGGGCGAGATACCATGACACTGATGC and GCGAGATACCATGACACTG
ATGC. M3 to S2 joint: antisense GluK2 GTCAATGGGCGACTCCATGC and
CATGCGTTCCACAGTCAGAAAGGC, sense GluN1 GAGTCGCCCATTGACG
GCATCAATGACCCCAGGCTC and GGCATCAATGACCCCAGGCTC, sense
GluN2B GAGTCGCCCATTGACGGCCTGAGTGACAAGAAGTTCC and GGCC
TGAGTGACAAGAAGTTCC. S2 to M4 joint: sense GluK2 CCGGAGGAGGAG
AGCAAAGAG and AAAGAGGCCAGTGCTCTGGG, antisense GluN1 GCTCT
CCTCCTCCGGGCATTCCTGATACCGAACCC and GCATTCCTGATACCGAA
CCC, antisense GluN2B GCTCTCCTCCTCCGGGCAAATGCCAGTGAGCCA
GAG and GCAAATGCCAGTGAGCCAGAG. M4 to CTD joint: sense GluN1
TGCCCAATTGAAGCAGATGCAGCTGG and sense GluN2B GCATCAATTGA
TGGGTGTCTGTTCTGG primers generate Mfe I sites (bold) to match the
endogenous unique site in GluK2. All constructs were sequenced by the
Washington University PNACL facility. cDNAs were expressed by transient
transfection in HEK 293 cells (ATCC) using lipofectamine 2000 (Invitrogen). The
cells were propagated in 25 cm2 ﬂasks with MEM plus 10% fetal bovine serum and
passaged once each week with protease XXIII (Sigma). Cells used for transfection
were seeded onto 12-well plates and transfected the following day. Co-expression of
GFP from a second vector was used to identify transfected cells. The day after
transfection, cells were plated at low density on 35mm plates that were coated with
nitrocellulose; recordings were obtained on the following 2 days.
Electrophysiology. Cultures were bath perfused with Tyrode’s solution (in mM):
150 NaCl, 4 KCl, 2 MgCl2, 2 CaCl2, 10 glucose, 10 HEPES, pH 7.4 with NaOH.
Whole-cell electrodes were pulled from borosilicate tubing (WPI) and ﬁlled with an
internal solution that contained (in mM): 140 Cs-glucuronate, 10 EGTA, 5 CsCl,
5 MgCl2, 5 ATP, 1 GTP, 0.02 spermine and 10 HEPES, pH adjusted to 7.4 with
CsOH. Agonists and antagonists were delivered in control extracellular solution
(160mM NaCl, 2mM CaCl2 and 10mM HEPES, pH adjusted to 7.4 with NaOH)
by local perfusion from a multi-barrelled pipette positioned near the recorded cell.
Currents were recorded with an Axopatch 200A ampliﬁer controlled by p-Clamp
software (Molecular Devices). Current-voltage relations were generated by aver-
aging the currents recorded during a series of ﬁve ascending and descending
membrane potential ramps (0.75mVms 1)13. Concentration response relations
were ﬁt with the Hill equation: I¼ Imax/(1þ (EC50/[agonist])^n). Results are
presented as mean±s.e.m. and were considered signiﬁcant for Po0.05. One-way
ANOVA and t-tests were performed with SigmaStat (Systat Software). Curve ﬁts
using different numbers of parameters were evaluated by F-tests13.
Molecular modelling. Homology modelling of a receptor composed of two pair of
chimeric subunits, N1/K2(R)þN2B/K2(R), was performed using modeller56
release 9v7; available at http://salilab.org/modeller/. The GluA2 tetramer crystal
structure (PDB ID: 3KG2) was used as the template with sequence alignment from
Fig. S2 of ref. 3 and twofold symmetry constraints for the A/C and B/D subunit
pairs.
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